Drug recall · July 8, 2020
Childrens Robitussin Honey Cough and Chest Congestion DM recall
Why: Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectorant), 4 FL OZ. bottle (118 mL), Distributed by: Pfizer, Madison, NJ 07940 USA, UPC: 50300318760128, NDC: 0031-8760-12.
- Lots / codes
Lot #s: 02177, 02178, Exp. 01/31/2022
- Quantity
- 132,336 bottles
- Company
- Glaxosmithkline Consumer Healthcare Holdings, Warren, NJ
- Distribution
- Nationwide in the US
- Initiated
- June 16, 2020 · Voluntary: Firm initiated
- Classified
- June 26, 2020
- Reported
- July 8, 2020
- Ended
- June 3, 2022
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dextromethorphan / guaifenesin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.